GORMAN KEVIN CHARLES bought NBIX

May 21, 2025 · Form 4 insider transaction

GORMAN KEVIN CHARLES bought 6,610 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

6,610

Price

$0.00

Total value

N/A

InsiderGORMAN KEVIN CHARLES

Role—

CompanyNeurocrine Biosciences, Inc. (NBIX)

SecurityNon-Qualified Stock Option

Transaction codeA — Grant or award

Transaction dateMay 21, 2025

Filing dateMay 22, 2025

Shares owned after6,610

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Option vests in 12 monthly installments beginning June 21, 2025.

View the original Form 4 on SEC EDGAR